Retatrutide

Retatrutide

Retatrutide

Retatrutide activates GLP-1, GIP, and glucagon receptors, regulating appetite, lipid metabolism, and energy balance. Enhances thermogenesis, inhibits fat deposition and maintains insulin sensitivity. It is effective in resistant forms of obesity and metabolic syndrome.

Raw Material USA
Country of Origin UAE
Purity 99%

Description
Retatrutide in ampoule form is a concentrated version of the triple GLP-1/GIP/GCGR agonist, designed for deep metabolic modulation. This format is used when a rapid response, amplified lipolytic activity, or additional support in metabolic resistance is required.

Retatrutide promotes substantial fat-mass reduction, improved glycemic balance, and higher energy expenditure by influencing both central appetite-regulation pathways and peripheral lipid-oxidation mechanisms. This makes it a key component in intensive weight-correction protocols and body-recomposition strategies.

Retatrutide Ampoule is suitable for patients who need a fast metabolic response and enhanced lipolytic activity. It is used in protocols targeting appetite regulation, body contour refinement, and restoration of metabolic sensitivity

Other peptides